KIROMIC BIOPHARMA INC (KRBP) Stock Analyst Earnings Estimates
NASDAQ:KRBP - Nasdaq - US4976342042 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | |||||||
| EBITDA YoY % growth | -5.27M | -3.1M 41.18% | -3.62M -16.77% | -19M -424.86% | -24.84M -30.74% | -29.45M -18.56% | N/A -22.53% | N/A -7.31% | |
| EBIT YoY % growth | -5.39M | -3.18M 41.00% | -3.71M -16.67% | -19.2M -417.52% | -25.31M -31.82% | -31.12M -22.96% | N/A -20.83% | N/A -7.22% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 96.10% | N/A 33.48% | N/A |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.44 42.67% | -0.50 12.50% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -16.20 -2,282.35% | -11.63 | -4.57 | -39.32% |
| Q1 2022 Q2Q % growth | -14.40 -2,616.98% | -8.87 | -5.53 | -62.27% |
| Q4 2021 Q2Q % growth | -22.80 | -11.63 | -11.17 | -96.08% |
| Q3 2021 Q2Q % growth | -12.00 | -7.96 | -4.04 | -50.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |